The DOI matches its Crossref record; 279 of the 279 references it cites were found in a registry or an index.
Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
Open accessAbstract
Dendritic cells (DC) are professional antigen presenting cells, uniquely able to induce naïve T cell activation and effector differentiation. They are, likewise, involved in the induction and maintenance of immune tolerance in homeostatic conditions. Their phenotypic and functional heterogeneity points to their great plasticity and ability to modulate, according to their microenvironment, the acquired immune response and, at the same time, makes their precise classification complex and frequently subject to reviews and improvement. This review will present general aspects of the DC physiology and classification and will address their potential and actual uses in the management of human disease, more specifically cancer, as therapeutic and monitoring tools. New combination treatments with the participation of DC will be also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–279 of 279
Dai, P., Wang, W., Yang, N., Serna‐Tamayo, C., Ricca, J. M., Zamarin, D., Shuman, S., Merghoub, T., Wolchok, J. D., & Deng, L. (2017) · Science Immunology · doi:10.1126/sciimmunol.aal1713 · Cited by 128
Monocyte-derived DC maturation strategies and related pathways: a transcriptional view
Castiello, L., Sabatino, M., Jin, P., Clayberger, C., Marincola, F. M., Krensky, A. M., & Stroncek, D. F. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0954-6 · Cited by 126
Regulation of TH17 cell differentiation by innate immune signals
Huang, G., Wang, Y., & Chi, H. (2012) · Cellular and Molecular Immunology · doi:10.1038/cmi.2012.10 · Cited by 123
Human Blood CD1c+ Dendritic Cells Promote Th1 and Th17 Effector Function in Memory CD4+ T Cells
Rojas, I. L., Mok, W. H., Pearson, F. E., Minoda, Y., Kenna, T., Barnard, R. T., & Radford, K. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00971 · Cited by 123
Dendritic Cells—A Conductor of T Cell Differentiation—
Kadowaki, N. (2007) · Allergology International · doi:10.2332/allergolint.r-07-146 · Cited by 117
Kuhn, S. P., Yang, J., & Ronchese, F. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00584 · Cited by 107
Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy
Sánchez-Paulete, A. R., Teijeira, Á., Cueto, F. J., Garasa, S., Perez‐Gracia, J. L., Sánchez-Arráez, Á., Sancho, D., & Melero, I. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx727 · Cited by 103
Cytokines and their effects on maturation, differentiation and migration of dendritic cells
Jonuleit, H., Knop, J. X. F. R., & Enk, A. (1996) · Archives of Dermatological Research · doi:10.1007/s004030050144 · Cited by 102
A20 Inhibits Toll-Like Receptor 2– and 4–Mediated Interleukin-8 Synthesis in Airway Epithelial Cells
Gon, Y., Asai, Y., Hashimoto, S., Mizumura, K., Jibiki, I., Machino, T., Ra, C., & Horie, T. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0438oc · Cited by 102
Ramos, R. N., Chin, L. S., dos Santos, A. P. S. D. A., Bergami-Santos, P. C., Laginha, F. M., & Barbuto, J. A. M. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0112048 · Cited by 98
Self-citationMetabolic Influences That Regulate Dendritic Cell Function in Tumors
Dong, H., & Bullock, T. N. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00024 · Cited by 96
van Dinther, D., Stolk, D. A., van de Ven, R., van Kooyk, Y., de Gruijl, T. D., & den Haan, J. M. M. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5mr0217-059rr · Cited by 94
Yates, S. F., Paterson, A. M., Nolan, K. F., Cobbold, S. P., Saunders, N. J. S. G., Waldmann, H., & Fairchild, P. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.967 · Cited by 92
Targeting Dendritic Cells in vivo for Cancer Therapy
Caminschi, I., Maraskovsky, E., & Heath, W. R. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00013 · Cited by 91
Regulation of Th2 Cell Immunity by Dendritic Cells
Na, H., Cho, M., & Chung, Y. (2016) · Immune Network · doi:10.4110/in.2016.16.1.1 · Cited by 90
George, T. C., Bilsborough, J., Viney, J. L., & Norment, A. M. (2003) · European Journal of Immunology · doi:10.1002/immu.200310026 · Cited by 89
Microbial-based therapy of cancer: Current progress and future prospects
Bernardes, N., Seruca, R., Chakrabarty, A. M., & Fialho, A. M. (2010) · Bioengineered Bugs · doi:10.4161/bbug.1.3.10903 · Cited by 89
Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+T cell recognition
Tullett, K. M., Rojas, I. L., Minoda, Y., Tan, P. S., Zhang, J., Smith, C., Khanna, R., Shortman, K., Caminschi, I., Lahoud, M. H., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87102 · Cited by 86
Verronèse, E., Delgado, A. S., Valladeau‐Guilemond, J., Garin, G., Guillemaut, S., Trédan, O., Ray-Coquard, I., Bachelot, T., Nkodia, A., Bardin-dit-Courageot, C., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1100791 · Cited by 82
García-Hernández, M. D. L. L., Uribe‐Uribe, N., Espinosa-González, R., Kast, W. M., Khader, S. A., & Rangel‐Moreno, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00563 · Cited by 80
Dendritic Cell-Based Therapeutic Cancer Vaccines: What We Have and What We Need
Kaliński, P., Urban, J. A., Narang, R., Berk, E., Wieckowski, E., & Muthuswamy, R. (2009) · Future Oncology · doi:10.2217/fon.09.6 · Cited by 78
Molecular Events of Bacterial-Induced Maturation ofDendritic Cells
Rescigno, M., Granucci, F., & Ricciardi‐Castagnoli, P. (2000) · Journal of Clinical Immunology · doi:10.1023/a:1006629328178 · Cited by 76
Mesenteric lymph node CD11b − CD103 + PD‐L1 High dendritic cells highly induce regulatory T cells
Shiokawa, A., Kotaki, R., Takano, T., Nakajima‐Adachi, H., & Hachimura, S. (2017) · Immunology · doi:10.1111/imm.12747 · Cited by 76
McCoy, K. D., Hermans, I. F., Fraser, J., Gros, G. S. L., & Ronchese, F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1157 · Cited by 75
Jensen, S. S., & Gad, M. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-37 · Cited by 72
Noguchi, M., Moriya, F., Koga, N., Matsueda, S., Sasada, T., Yamada, A., Kakuma, T., & Itoh, K. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1781-6 · Cited by 72
Tumor microenvironment–associated modifications of alternative splicing
Brosseau, J., Lucier, J., Nwilati, H., Thibault, P., Garneau, D., Gendron, D., Durand, M., Couture, S., Lapointe, E., Prinos, P., et al. (2013) · RNA · doi:10.1261/rna.042168.113 · Cited by 71
Physiologic Control of IDO Competence in Splenic Dendritic Cells
Baban, B., Chandler, P., Johnson, B. A., Huang, L., Li, M., Sharpe, M. L., Francisco, L. M., Sharpe, A. H., Blazar, B. R., Munn, D. H., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100276 · Cited by 70
Modulation of innate immunity in the tumor microenvironment
González-Gugel, E., Saxena, M., & Bhardwaj, N. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1859-9 · Cited by 69
Harnessing dendritic cells for immunotherapy
Delamarre, L., & Mellman, I. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.02.001 · Cited by 68
Sims, R. B. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.11.058 · Cited by 68
Diversity of Pathogen Sensors in Dendritic Cells
Cerboni, S., Gentili, M., & Manel, N. (2013) · Advances in immunology · doi:10.1016/b978-0-12-417028-5.00008-9 · Cited by 67
Orsini, G., Legitimo, A., Failli, A., Ferrari, P., Nicolini, A., Spisni, R., Miccoli, P., & Consolini, R. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122022 · Cited by 65
Dendritic cell–epithelial cell crosstalk in the gut
Rescigno, M. (2014) · Immunological Reviews · doi:10.1111/imr.12181 · Cited by 64
Hebel, K., Griewank, K., Inamine, A., Chang, H., Müller‐Hilke, B., Fillatreau, S., Manz, R. A., Radbruch, A., & Jung, S. (2006) · European Journal of Immunology · doi:10.1002/eji.200636356 · Cited by 62
Coulon, P.-G. A., Richetta, C., Rouers, A., Blanchet, F. P., Urrutia, A., Guerbois, M., Piguet, V., Theodorou, I. D., Bet, A., Schwartz, O., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600286 · Cited by 62
Proietto, A., Mittag, D., Roberts, A. W., Sprigg, N. S., & Wu, L. (2012) · Cellular and Molecular Immunology · doi:10.1038/cmi.2012.48 · Cited by 61
Drutman, S. B., Kendall, J. C., & Trombetta, E. S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102741 · Cited by 61
Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines
Saxena, M., & Bhardwaj, N. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.06.003 · Cited by 60
Inhibiting STAT5 by the BET Bromodomain Inhibitor JQ1 Disrupts Human Dendritic Cell Maturation
Toniolo, P. A., Liu, S., Yeh, J., Moraes‐Vieira, P. M., Walker, S. R., Vafaizadeh, V., Barbuto, J. A. M., & Frank, D. A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401635 · Cited by 59
Self-citationStill Alive and Kicking: In-Vitro-Generated GM-CSF Dendritic Cells!
Lutz, M. B., Inaba, K., Schuler, G., & Romani, N. (2016) · Immunity · doi:10.1016/j.immuni.2015.12.013 · Cited by 58
Farkas, Á., & Kemény, L. V. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10301.x · Cited by 56
Lowe, D. B., Bose, A., Taylor, J. L., Tawbi, H. A.-H., Lin, Y., Kirkwood, J. M., & Storkus, W. J. (2014) · OncoImmunology · doi:10.4161/onci.27589 · Cited by 54
Dauer, M., Schad, K., Herten, J., Junkmann, J., Bauer, C. A., Kiefl, R., Endres, S., & Eigler, A. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.05.010 · Cited by 53
Ouyang, M., White, E. E., Ren, H., Guo, Q., Zhang, I., Gao, H., Song, Y., Chen, X., Weng, Y., Fonseca, A. D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148139 · Cited by 53
Paul, J. M. (2007) · Frontiers in bioscience · doi:10.2741/2371 · Cited by 51
Kuhn, S. P., Hyde, E. J., Yang, J., Rich, F. J., Harper, J. L., Kirman, J. R., & Ronchese, F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301135 · Cited by 49
Silva‐Cardoso, S. C., Affandi, A. J., Spel, L., Cossu, M., van Roon, J. A. G., Boes, M. L., & Radstake, T. R. D. J. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602020 · Cited by 48
Baleeiro, R. B., Anselmo, L. B., Soares, F. A., Pinto, C. A. L., Ramos, O., Gross, J. L., Haddad, F. J., Younes, R. N., Tomiyoshi, M. Y., Bergami-Santos, P. C., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0468-7 · Cited by 47
Self-citationFailli, A., Legitimo, A., Orsini, G., Romanini, A., & Consolini, R. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.013 · Cited by 46
Toll-Like Receptors and Skin Cancer
Burns, E. M., & Yusuf, N. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00135 · Cited by 46
Luft, T., Rodionova, E., Maraskovsky, E., Kirsch, M., Heß, M., Buchholtz, C., Göerner, M., Schnurr, M. M., Skoda, R. C., & Ho, A. D. (2006) · Blood · doi:10.1182/blood-2005-04-1501 · Cited by 45
Müller, P., Rothschild, S. I., Walter, A., Hirschmann, P., Horvath, L., Bubendorf, L., Savic, S., & Zippelius, A. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1768-3 · Cited by 44
Alvarez, K. L. F., Beldi, M. C., Sarmanho, F., Rossetti, R. A. M., Silveira, C. R. F., Mota, G. R., Andreoli, M. A., Caruso, E. D. D. C., Kamillos, M. F., Souza, A. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09079-3 · Cited by 44
Self-citationHarris, K. M. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311132 · Cited by 43
Dendritic cells and complement: at the cross road of innate and adaptive immunity
Castellano, G., Woltman, A. M., Schena, F. P., Roos, A., Daha, M. R., & van Kooten, C. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.03.018 · Cited by 41
The Invisible Arm of Immunity in Common Cancer Chemoprevention Agents
Marzbani, E., Inatsuka, C., Lu, H., & Disis, M. L. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0036 · Cited by 41
A Death Notice for In-Vitro-Generated GM-CSF Dendritic Cells?
Guilliams, M., & Malissen, B. (2015) · Immunity · doi:10.1016/j.immuni.2015.05.020 · Cited by 38
Deregulation of SOCS5 suppresses dendritic cell function in chronic lymphocytic leukemia
Toniolo, P. A., Liu, S., Yeh, J., Ye, D. Q., Barbuto, J. A. M., & Frank, D. A. (2016) · Oncotarget · doi:10.18632/oncotarget.10093 · Cited by 38
Self-citationClonal analysis of human dendritic cell progenitor using a stromal cell culture
Lee, J., Breton, G., Aljoufi, A., et al. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.06.004 · Cited by 37
STAT3 and NF-κB are Simultaneously Suppressed in Dendritic Cells in Lung Cancer
Li, R., Fang, F., Jiang, M., Wang, C., Ma, J., Kang, W., Zhang, Q., Miao, Y., Wang, D., Guo, Y., et al. (2017) · Scientific Reports · doi:10.1038/srep45395 · Cited by 37
Sato, T., Kitawaki, T., Fujita, H., Iwata, M., Iyoda, T., Inaba, K., Ohteki, T., Hasegawa, S., Kawada, K., Sakai, Y., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203517 · Cited by 34
Pinho, M. P., Sundarasetty, B. S., Bergami-Santos, P. C., et al. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.01.005 · Cited by 34
Self-citationFry, T. J., Shand, J. L., Milliron, M., Tasian, S. K., & Mackall, C. L. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0638-7 · Cited by 33
Evans, V. A., Lal, L., Akkina, R., Solomon, A. E., Wright, E., Lewin, S. R., & Cameron, P. U. (2011) · Retrovirology · doi:10.1186/1742-4690-8-43 · Cited by 32
Helft, J., Böttcher, J. P., Chakravarty, P., Zelenay, S., Huotari, J., Schraml, B. U., Goubau, D., & Sousa, C. R. E. (2016) · Immunity · doi:10.1016/j.immuni.2015.12.014 · Cited by 31
Shen, J., Wang, L., Zou, Z., Kong, W.-W., Yan, J., Meng, F., Chen, F., Du, J., Shao, J., Xu, Q.-P., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i29.5395 · Cited by 31
Vega‐Ramos, J., Roquilly, A., Asehnoune, K., & Villadangos, J. A. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.07.013 · Cited by 26
Lentivirus-Induced Dendritic Cells for Immunization Against High-Risk WT1 + Acute Myeloid Leukemia
Sundarasetty, B. S., Singh, V. K., Salguero, G., Geffers, R., Rickmann, M., Macke, L. A., Borchers, S., Figueiredo, C., Schambach, A., Gullberg, U., et al. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.128 · Cited by 25
Radiotherapy in the age of cancer immunology: Current concepts and future developments
Loi, M., Desideri, I., Greto, D., Mangoni, M., Sottili, M., Meattini, I., Becherini, C., Terziani, F., Paoli, C. D., Olmetto, E., et al. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.02.002 · Cited by 24
Differentiation of human dendritic cell subsets for immune tolerance induction
Deluce, N. K.-N., Lamendour, L., Chabot, V., Héraud, A., Ivanović, Z., Halary, F. A., Dehaut, F., & Velge-Roussel, F. (2017) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2017.08.002 · Cited by 24
Sakamoto, C., Kohara, H., Inoue, H., Narusawa, M., Ogawa, Y., Hirose, L., Miyamoto, S., Matsumura, Y., Yamada, K., Takahashi, A., et al. (2017) · Cancer Gene Therapy · doi:10.1038/cgt.2016.80 · Cited by 23
Tolerogenic dendritic cells generated by RelB silencing using shRNA prevent acute rejection
Zhu, H., Qiu, T., Liu, X., Dong, W.-C., Weng, X., Hu, C., Kuang, Y., Gao, R.-H., Dan, C., & Tao, T. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.02.012 · Cited by 21
Sela, U., Park, C. G., Park, A., Olds, P., Wang, S., Steinman, R. M., & Fischetti, V. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146412 · Cited by 21
Barbuto, J. A. M. (2013) · Immunotherapy · doi:10.2217/imt.12.153 · Cited by 18
Self-citationClavijo-Salomon, M. A., Ramos, R. N., Crippa, A., Pizzo, C. R., Bergami-Santos, P. C., & Barbuto, J. A. M. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1625-9 · Cited by 15
Self-citationMonocyte-derived dendritic cells from patients with cervical intraepithelial lesions
Lopes, A. M. M., Michelin, M. A., & Murta, E. F. C. (2017) · Oncology Letters · doi:10.3892/ol.2017.5595 · Cited by 14
Fecek, R. J., & Storkus, W. J. (2016) · Immunotherapy · doi:10.2217/imt-2016-0071 · Cited by 13
Clavijo-Salomon, M. A., Bergami-Santos, P. C., & Barbuto, J. A. M. (2017) · Immunotherapy · doi:10.2217/imt-2016-0145 · Cited by 5
Self-citation
Cited by
Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine
Sousa de Almeida, M., Susnik, E., Drasler, B., Taladriz-Blanco, P., Petri-Fink, A., & Rothen-Rutishauser, B. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01127d · Cited by 1,079
Kologrivova, I., Shtatolkina, M., Suslova, T., & Ryabov, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.664457 · Cited by 317
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Antitumour dendritic cell vaccination in a priming and boosting approach
Harari, A., Graciotti, M., Bassani-Sternberg, M., & Kandalaft, L. E. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0074-8 · Cited by 271
Momin, M. Y., Gaddam, R. R., Kravitz, M., Gupta, A., & Vikram, A. (2021) · Cells · doi:10.3390/cells10113097 · Cited by 107
Metadata
- Authors
- Patente, T. A., Pinho, M. P., Oliveira, A. A., Evangelista, G. C. M., Bergami-Santos, P. C., & Barbuto, J. A. M.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-01-21
- Volume
- 9
- Pages
- 3176-3176
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2913970879
- Cited by
- 392
- References
- 279
- FWCI
- 14.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.